Category: Fundamentals β-blockers are no longer recommended as first-line treatment for hypertension by the Joint National Council (JNC) of the USA and have been relegated to fourth or even fifth line choices by the National Institute of Clinical Excellence of the UK.
No comments :
Post a Comment